Ijada C Fields

Ijada Fields serves as a key procurement professional within the National Institute of Child Health and Human Development (NICHD), supporting the agency’s mission to advance biomedical discovery through strategic acquisition of specialized scientific infrastructure and technical services. Responsible for managing complex contracting actions, Fields oversees the procurement of high-precision analytical instrumentation, laboratory maintenance services, and research support solutions critical to life sciences innovation. Their work ensures that NICHD’s research facilities remain equipped with cutting-edge capabilities to study human development, reproductive health, and pediatric outcomes, aligning procurement strategy with the institute’s scientific priorities and operational needs. While specific contractor names are not publicly disclosed, Fields maintains a broad network of vendor partnerships with firms specializing in analytical instrument manufacturing, life sciences R&D, and laboratory systems support. Relationships are characterized by technical alignment and compliance with federal acquisition regulations, with an emphasis on performance-based contracting and long-term service agreements for sensitive equipment. Vendor engagement prioritizes technical capability, quality assurance, and adherence to laboratory accreditation standards. Fields demonstrates a strong preference for open competition, with 100% of acquisitions conducted without set-asides, indicating a focus on technical merit and market-wide competition rather than socioeconomic preferences. This approach reflects NICHD’s need for specialized expertise often found only among large, highly qualified industry players with proven capabilities in high-stakes scientific environments. The primary NAICS categories under Fields’ purview include 541990 (other professional scientific services), 334516 (analytical laboratory instrument manufacturing), and 541715 (R&D in life sciences). These reflect a deep specialization in procuring mass spectrometers, chromatography systems, automated cell analysis platforms, and contract research services supporting developmental biology and clinical translational studies. Their expertise lies at the intersection of scientific rigor and federal acquisition compliance, ensuring that NICHD’s infrastructure remains at the forefront of biomedical innovation.